Pfizer and Amazon Web Services are just another example of how artificial intelligence is working in the background in healthcare.
In this article, we discuss 12 very high yield dividend stocks with upside potential. You can skip our detailed analysis of dividend stocks and their performance in the past, and go directly to read 5 Very High Yield Dividend Stocks With Upside Potential. Many investors are drawn to dividend investing for various reasons, but among […]
Pfizer Inc is disappointed in its performance versus rival GSK in the RSV vaccine market and is working to pick up market share in 2024, Chief Financial Officer David Denton said on Tuesday. Reuters reported in October that Pfizer's shot was lagging behind the GSK vaccine, which accounted for close to two-thirds of RSV shots given in the U.S. since early September. "If you look at our market share, I don't think we performed as well as we thought we could, or we think we will going forward," Denton told investors at a conference hosted by Evercore ISI analysts.